NCT02448680
A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa No drug interventions treatment 3 completed NCT02020369
Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors treatment 3 completed NCT02484638
Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors treatment 2 / 3 terminated NCT06568302
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial treatment 3 recruiting NCT04647227
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors treatment 4 recruiting NCT05789537
A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors treatment 2 recruiting NCT06010953
SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment No drug interventions treatment 1 / 2 completed NCT05651061
A Phase I of SS109 in Hemophilia A or and B With Inhibitors No drug interventions treatment 1 completed NCT03372993
Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven No drug interventions Not Available Not Available completed NCT04489537
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B No drug interventions treatment 3 terminated NCT03818529
ATHN 8: Previously Untreated Patients (PUPs) Matter Study No drug interventions Not Available Not Available completed NCT04789954
Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors treatment 0 completed NCT03407651
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B treatment 2 completed NCT04072237
Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia No drug interventions diagnostic 1 completed NCT06312475
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors No drug interventions treatment 3 recruiting NCT04768699
Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia. treatment 1 unknown_status NCT03619863
ATHN 7: Hemophilia Natural History Study No drug interventions Not Available Not Available active_not_recruiting NCT00571584
High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors treatment 4 completed NCT03196284
A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors treatment 2 completed NCT00703911
Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors Not Available Not Available completed NCT01563471
Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers treatment 1 completed NCT00882778
PROPACT: Retrospective Prophylaxis Patient Case Collection Not Available Not Available completed NCT01988532
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia No drug interventions Not Available Not Available completed NCT00710619
Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX Not Available Not Available completed NCT01561924
Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography diagnostic 1 completed NCT00108758
Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia treatment 2 completed NCT01561391
Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery treatment 4 completed NCT01949792
A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors treatment 1 completed NCT01503567
Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries No drug interventions Not Available Not Available completed NCT01579968
Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery Not Available Not Available completed NCT01830712
A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors Not Available Not Available completed NCT04083781
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors treatment 3 active_not_recruiting NCT03741881
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) No drug interventions Not Available Not Available completed NCT01579955
Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice Not Available Not Available completed NCT01392547
Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors treatment 3 completed NCT00951405
Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors prevention 2 completed NCT00108797
Trial of NovoSeven® in Haemophilia - Joint Bleeds treatment 4 completed NCT02541942
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial No drug interventions other 2 completed NCT01586936
Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors Not Available Not Available completed NCT01561417
Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects treatment 1 completed NCT01322620
Survey Evaluating the Psychosocial Effects of Living With Haemophilia No drug interventions Not Available Not Available completed NCT02241694
To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives No drug interventions Not Available Not Available completed NCT02084810
Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects treatment 1 withdrawn